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Abstract
Background: Technology-mediated neurorehabilitation is suggested to enhance training intensity and therefore
functional gains. Here, we used a novel virtual reality (VR) system for task-specific upper extremity training after
stroke. The system offers interactive exercises integrating motor priming techniques and embodied visuomotor
feedback. In this pilot study, we examined (i) rehabilitation dose and training intensity, (ii) functional improvements,
and (iii) safety and tolerance when exposed to intensive VR rehabilitation.
Methods: Ten outpatient stroke survivors with chronic (>6 months) upper extremity paresis participated in a ten-
session VR-based upper limb rehabilitation program (2 sessions/week).
Results: All participants completed all sessions of the treatment. In total, they received a median of 403 min of
upper limb therapy, with 290 min of effective training. Within that time, participants performed a median of 4713
goal-directed movements. Importantly, training intensity increased progressively across sessions from 13.2 to 17.3
movements per minute. Clinical measures show that despite being in the chronic phase, where recovery potential
is thought to be limited, participants showed a median improvement rate of 5.3% in motor function (Fugl-Meyer
Assessment for Upper Extremity; FMA-UE) post intervention compared to baseline, and of 15.4% at one-month
follow-up. For three of them, this improvement was clinically significant. A significant improvement in shoulder
active range of motion (AROM) was also observed at follow-up. Participants reported very low levels of pain, stress
and fatigue following each session of training, indicating that the intensive VR intervention was well tolerated. No
severe adverse events were reported. All participants expressed their interest in continuing the intervention at the
hospital or even at home, suggesting high levels of adherence and motivation for the provided intervention.
Conclusions: This pilot study showed how a dedicated VR system could deliver high rehabilitation doses and,
importantly, intensive training in chronic stroke survivors. FMA-UE and AROM results suggest that task-specific VR
training may be beneficial for further functional recovery both in the chronic stage of stroke. Longitudinal studies
with higher doses and sample sizes are required to confirm the therapy effectiveness.
Trial registration: This trial was retrospectively registered at ClinicalTrials.gov database (registration number
NCT03094650) on 14 March 2017.
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Background
Stroke affects about 17 million people per year world-
wide, with an increasing rate every year [1]. Stroke survi-
vors often suffer from physical and mental disabilities,
heavily impacting their quality of life. Five years after the
first stroke, nearly 66% of patients exhibit different de-
grees of disability and only 34% are functionally inde-
pendent in their activities of daily living [2].
Motor rehabilitation after stroke
Motor dysfunction is the most prevalent impairment,
with 9 out of 10 stroke survivors suffering from some
form of upper limb motor disability [3], and it is a strong
predictor of poor functional recovery [4]. Thus, there is a
strong need for rehabilitative approaches enhancing motor
recovery for stroke patients [5]. To maximize neural,
motor and functional recovery, training needs to be long-
lasting, challenging, repetitive, task-specific, motivating,
salient, and intensive [6]. Standard motor rehabilitation
after stroke typically includes neurofacilitation techniques,
task-specific training and task-oriented training [7]. Fur-
ther approaches include strength training, trunk restraint,
somatosensory training, constraint-induced movement
therapy, bilateral arm training, coordination of reach to
grasp, mirror training, action observation and neuromus-
cular electrical stimulation [8].
Time scheduled for therapy and its frequency are de-
terminant factors for the outcome of motor rehabilita-
tion [9], with a recommended initial amount of at least
45 min for a minimum of 5 days per week [10]. How-
ever, the frequency of the delivered therapy usually de-
creases with time, with therapy being discontinued
between 3 and 6 months after the vascular accident [7].
Under these rehabilitation conditions, recovery of motor
function has been observed to be strongest during the
first month after stroke and to slow down during subse-
quent months, reaching a “plateau” by 3–6 months post
stroke [11, 12]. Clinical evidence for motor improvement
in chronic stroke [13] suggests that the “plateau” may
depend not only on neurobiological factors, but may also
be caused by other factors such as reduction in rehabili-
tation services [14].
Thus, increasing therapy dose, also in the chronic phase
of the disease, might be a critical factor to achieve a posi-
tive outcome. Although several guidelines for upper limb
rehabilitation have been recently issued [5, 10], the rela-
tionship between training intensity and recovery patterns
is not yet fully established. Indeed, it is not fully clear how
to quantify the dose increase leading to a positive out-
come. Training volume, understood as the number of
repetitions, seems to be a more relevant parameter of dose
than just the total time allocated for therapy [9]. An
important issue is how to quantify and capture this con-
cept in a measurable parameter. Intensity of training,
understood as the number of repetitions divided by the
number of minutes of active therapy, might be a funda-
mental factor (together with amount and frequency of
therapy) to quantify training efficiency. This knowledge
becomes critical in order to evaluate cost-effectiveness of
new technology-mediated interventions and to select
the most valuable therapy procedures at the different
stages of the continuum of care for stroke survivors.
Virtual reality for motor rehabilitation
Different complementary solutions have been proposed
during the last decades to help increase and maintain
the rehabilitation dose in the long term, mainly through
continued therapy. Virtual reality (VR) based motor re-
habilitation is a relatively recent approach, showing evi-
dence of moderate effectiveness in improving upper
limb and ADL function when compared to conventional
therapy [15].
Many VR setups, and often generic (i.e. not developed
for rehabilitation purposes) commercial off-the-shelf
computer games, are used to perform a series of exer-
cises, where patients move in front of a console and re-
ceive mostly visual feedback about their movements
[16–18]. This represents a limited approach, whereby the
level of immersion and potential feedback is restricted to a
single sensorimotor action-perception loop: the patient
moves and receives only abstract visual feedback from the
screen. A rather different approach implies embodied
sensorimotor feedback, where movements of the patient
in the real world are reproduced as movements of an an-
thropomorphic avatar in the virtual environment. Under
such conditions, VR allows for more elaborated sensori-
motor activation, which may impact the recovery process.
In particular, through sensorimotor resonance mecha-
nisms, embodied sensorimotor feedback allows the inte-
gration of motor priming techniques and cognitive
principles related to body perception and action, including
mirror therapy [19] and action observation [20, 21], which
have been shown to improve functional recovery and in-
crease cortical activation of the ipsilesional side after
stroke. This embodied technology can be achieved by
using motion capture technology that interprets the pa-
tient’s movements and provides multisensory (vision,
audio, touch) feedback to the user about the movement
performance. Such enriched VR experiences have been
demonstrated to increase patients’ motivation [22] and fa-
cilitate functional recovery by engaging appropriate neural
circuits in the motor system [23].
One of the VR advantages is that it enables simulated
practice of functional tasks at a higher dosage than trad-
itional therapies [15]. Lohse and colleagues recently
reviewed the duration, time and frequency scheduled for
different VR and computer games interventions, but
training intensity (as defined above) was no reported
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[24]. In general, authors reported an overall median of
570 min of VR (or computer games) therapy delivered,
with duration ranging from 20 to 60 min per session,
and 8 to 36 sessions [24]. Otherwise, intensity of training
is rarely reported for VR training (see [25] for an excep-
tion). However, this is a critical factor to estimate cost-
effectiveness of VR-based interventions.
Objectives of the study
The present study aims at investigating the feasibility of
admninistering intensive training in chronic stroke pa-
tients using a dedicated VR-based system that embeds
real-time 3D motion capture and embodied visual feed-
back to deliver functional exercises designed to train im-
paired motor skills of the upper limb. Our primary goal
was to assess (i) rehabilitation dose and training intensity in
chronic patients. Additionally, we asked (ii) whether
chronic stroke survivors improve functional outcomes of
the upper limb when exposed to intensive VR-based ther-
apy, and we measured (iii) safety and tolerance to such a
technology-mediated intervention. We hypothesize that in-
tensive VR-based rehabilitation may lead to high rehabilita-
tion doses and functional improvement in chronic
stroke survivors.
Material and methods
Participants
Ten chronic (>6 months from stroke onset) outpatient
stroke survivors with hemiparesis participated in the study
(age: 54.9 ± 13.1 years; 6 females; time after stroke: 6 to
108 months; see Table 1). They were recruited from the
“Clinique Romande de Réadaptation” (Sion, Switzerland)
from February to October 2015. They were selected
following the inclusion and exclusion criteria listed in
Table 2.
Experimental procedure
This was a single-group and blinded-assessor interven-
tion study, with a physical therapist delivering the
therapy, and a second therapist carrying out the pre-
and post-intervention assessments. The blinded assessor
was not aware of the therapy details, including exercise
schedule, dose or training intensity. The clinical protocol
was approved by the Ethics Committee of the Canton of
Valais (Switzerland). All participants provided their writ-
ten informed consent prior to enrolment. They were re-
imbursed for their transportation expenses.
The intervention consisted of 10 one-hour training
sessions of VR, with a frequency of two sessions per
week over a period of 5 weeks. At each session, the par-
ticipants sat in a comfortable chair with armrests in
front of a table with their feet resting on the floor or on
a footstool if needed. The VR system was placed on the
table, leaving enough workspace for participants to
complete the exercises. A physical therapist freely ad-
ministered the upper limb therapy content using the VR
system, selecting the task/exercise and training modality,
and gradually adjusting its difficulty level (e.g. asking the
participant to carry it out against gravity or gravity-
compensated) according to the participant’s needs and
abilities, but without assisting participants physically. At
each session, participants completed a series of assess-
ments before and after the training period (see section
2.4). Besides the VR sessions, the participants were
allowed to continue their usual therapy sessions and
activities of daily living.
The assessor evaluated the participants at baseline (T0),
post-treatment (T1) and at 4-week follow-up (T2). The
baseline assessment was conducted prior to the beginning
of the training. The post-treatment assessment was con-
ducted after a 20-min break after the last training session.
Follow-up assessments were completed four weeks after
the end of the training (i.e., nine weeks after baseline).
Virtual reality system
The interventional device was a tabletop version of Mind-
Motion™ PRO (MindMaze SA, Switzerland), a VR-based
motor rehabilitation system developed for functional
Table 1 Demographic data of participants
Patient Age (years) Gender Stroke Time from stroke (months)
P1 43 F Right Sylvian ischemic 51
P2 50 M Left Sylvian ischemic 26
P3 55 F Right Sylvian ischemic 108
P4 38 F Left rupture cerebral aneurysm Sylvian 6
P5 64 M Left Sylvian ischemic 9
P6 64 M Left pontine ischemic 22
P7 72 M Right Sylvian sub-cortical ischemic 72
P8 34 F Left Sylvian ischemic 6
P9 68 F Right Sylvian ischemic 42
P10 61 F Right anterior communicating artery ischemic 54
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training of upper limb after brain damage. Exercises of the
MindMotion™ PRO are presented in game-like scenarios
designed to increase patients’ motivation and therapy
dose. The mobile platform is composed of a 3D motion
tracking camera (MindMaze SA), and a touch screen with
an embedded computer. The 3D motion tracking camera
captures and interprets participant’s movements, quantify-
ing upper limb and trunk joints angles by using passive
colored markers (Fig. 1a). For tracking of the forearm
(supination and pronation) and wrist (flexion-extension,
ulnar-radial deviation) movements, wireless inertial
trackers using Bluetooth technology are used. These
movements are then mapped to an avatar (i.e., a virtual
character) in the virtual environment. The avatar, seen
from a first-person or third-person perspective, repro-
duces the participant’s movements in real time (Fig. 1), en-
suring visuomotor synchrony and closed-loop via
embodied visual feedback (participant identifies his/her
own movements in those of the avatar). The touch screen
includes a button that allows the user to switch between
the therapist interface, where therapist composes and
launches the exercises, and the patient interface, which
displays the virtual environment for the VR exercises.
Through the user interface, therapist prescribes the appro-
priate exercises by selecting them from the available set,
indicating the body side to be used, the visual feedback
modality, difficulty level and number of repetitions. The
device’s database stores all information related to therapy
execution, therefore allowing for accurate quantification
of training intensity.
The rehabilitation exercises
The system offers interactive VR exercises that engage
participants' shoulder, elbow, forearm and wrist move-
ments with various levels of difficulty. These movements
are integrated into functional tasks that include pointing,
reaching and grasping virtual objects. The pointing exer-
cise consists of aiming at the center of a target with the
forearm or wrist during a few seconds. In the reaching
task (Fig. 1b), the participant has to extend the arm to
hit virtual objects placed on a virtual table within the
peripersonal space. The grasping game consists of grab-
bing a virtual object in the vertical plane (illustrated in
Fig. 1a) and dropping it in a new location. The most
solicited joint movements include: shoulder flexion/ex-
tension, shoulder horizontal abduction/adduction, shoul-
der internal/external rotation, and elbow flexion/
extension. Each exercise includes a variant to addition-
ally train forearm pronation/supination and wrist
flexion/extension. All exercises are played from a first-
person perspective and can be done with participants
Table 2 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Ischemic or hemorrhagic
minor-to-moderate (0 < NIHSS < 16)
stroke with hemiparesis and experi-
encing arm motor difficulties
• At least 6 months after stroke
incident
• Maximum 4 on the Medical
Research Council Scale (MRCS) for
shoulder elevation and elbow
flexion/extension
• 18 years and older
• First ever stroke
• Participating in another
movement treatment study at the
time of the present study
• Severe cognitive impairment
(Mini Mental Status Examination
score < 18 points)
• Orthopedic impairment or visual
disorders limiting the treatment
• Unable to give informed consent
form
• Risk of epileptic seizures
Fig. 1 a Participant performing an upper limb exercise (Grasping) with the MindMotion ™ PRO technology; b Participant doing the Reaching
exercise; c Participant doing a Fruitchamp exercise
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sliding their arms on the table surface, to help to com-
pensate for gravity. When needed, therapists offered to use
a small towel to ease sliding of the arm over the table sur-
face. These tasks aim at improving movement stability,
trajectory accuracy, and muscle strength against gravity.
An additional exercise in an enriched scenario, where a
ninja seen from a third-person perspective cuts fruits
appearing on the screen, develops participants' range of
motion and motor control while increasing speed and ac-
curacy of movements of the forearm and wrist (Fig. 1c).
After each repetition, participants receive a score based
on their motor performance (i.e., movement stability, tra-
jectory accuracy) as a reward for enhancing their
motivation.
The system also includes a virtual mirror mode avail-
able for all exercises, where movements of the un-
affected arm control the movements of the contralateral
virtual arm, providing the visuomotor illusion of move-
ment of the affected arm. Therapists were encouraged to
promote activity of the affected arm using the direct
mode, however they could freely select the mirror mode
when appropriate, e.g. for the affected arm to get some
rest if fatigue appears. Additionally, and in line with the
concept of constraint-induced movement training that
forces use of the affected hand [26], the virtual exercises
with MindMotion™ PRO software allow to select the tar-
geted arm (left/right) for the game control, so that the
participant can progress only if the targeted limb is used.
Outcome measures
Primary outcomes
Rehabilitation dose and training intensity Rehabilita-
tion dose and training intensity were quantified accord-
ing to the following variables:
i. Duration of the training session, defined as the
number of minutes from the beginning of the first
exercise of the session to the end of the last exercise
of the session.
ii. Effective training time, defined as the number of
minutes a participant actively trained during each
session. Breaks between exercises were excluded
from this measure.
iii. Number of goal-directed movements, defined as the
sum of intended movements (e.g. elbow extension to
reach, shoulder internal rotation to point, elbow
flexion to come back to initial position) to achieve a
task, per session and in total.
iv. Number of goal-directed movements per minute of
effective training time.
Importantly, the total number of goal-directed move-
ments reflects the overall rehabilitation dose. The num-
ber of goal-directed movements per minute of effective
training time yields an estimate of the intensity of the
training. All the recorded times were extracted from the
database of the VR system.
Secondary outcomes
Upper limb function Upper limb function was assessed
with the Fugl-Meyer Assessment for Upper Extremity
(FMA-UE), a stroke-specific test to measure motor im-
pairment and determine motor recovery [27]. In chronic
stroke, the minimal clinically important difference
(MCID) for the overall upper limb function measured
with FMA-UE is 5.25 over a maximum score of 66 [28].
FMA-UE was administered at baseline (T0), after com-
pletion of the last treatment session (T1), and at follow-
up one month after completion of the training (T2).
Active range of motion Active range of motion
(AROM) of shoulder flexion (0° position: arm by side
aligned between shoulder and hip), elbow extension (0°
position: fully extended elbow; humerus and radius
aligned), wrist extension (0° position: hand resting on
table with palm facing down), forearm supination (0°
position: thumb oriented up towards ceiling) and prona-
tion (0° position: thumb oriented up towards ceiling)
was measured with a goniometer in a standardized way
(neutral zero method) [29]. This measure evaluates par-
ticipant’s capacity to perform isolated joint movements.
Muscle strength Muscle strength for each joint was
assessed with the Modified Medical Research Council
Scale (mMRCS) [30].
Functional independence Functional independence
was assessed with the Functional Independence Measure
(FIM; maximal score: 126), which evaluates motor func-
tion and socio-cognitive skills [31].
Pain ratings In addition to the questions related to ad-
verse events, we measured pain level at each joint
(shoulder, elbow, wrist) at the beginning of each session
using an 11-point visual analog scale (VAS) [32].
AROM, mMRCS, FIM and pain VAS were adminis-
tered at baseline (T0), after completion of the last treat-
ment session (T1), and during a follow-up visit one
month after completion of the training (T2).
Safety and acceptance of technology
Before and at the end of each session, participants an-
swered 15 questions that evaluate different aspects on
safety and acceptance of the technology:
Tolerance to VR intervention Q1-Q4 were related to
fatigue and relaxation, comparing participant’s states im-
mediately before and after each session (Table 6). This
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comparison provided us information whether therapy
sessions increased fatigue and stress levels. This infor-
mation was recorded at every session.
Adverse event monitoring Q5 referred to any pain ex-
perience during the training (Table 6). This information
was recorded at every session. Besides questionnaire,
participants were debriefed at the end of each session.
Self-evaluation Q6 assessed self-reported movement
improvements (Table 6). This information was recorded
at every session.
Acceptance of technology Q7-Q8 evaluated the degree
of concentration and immersion into the VR exercises.
Q9 reported on the motion tracking accuracy. Q10-Q13
reflected participant’s attitude towards the technology.
This information was recorded at first and last sessions
(Table 7).
Motivation Q14-Q15 referred to participant’s motiv-
ation to continue the therapy at the hospital and at
home (Table 7). This information was recorded at first
and last sessions.
To quantify participant’s responses, we used a 7-point
colored visual scale, with participants pointing to the
level that corresponded best to their state, which was
translated into a 7-point ordinal scale (1 = completely
disagree, 7 = completely agree). After the questionnaire,
participants had the chance to give any additional feed-
back regarding the exercises and treatment.
Data analysis
Data analysis was conducted with R software [33]. We
used Wilcoxon signed-rank test for the single compari-
sons (last vs. first session) of the rehabilitation dose and
training intensity measures. We applied non-parametric
Friedman test to evaluate changes in the secondary out-
come measures from baseline (T0) to post-intervention
(T1) and follow-up (T2). We also used Wilcoxon
signed-rank test for the post-hoc analyses, and reported
effect sizes (r) [34]. Improvement rate in FMA-UE was
computed as the improvement percentage with respect
to the potential full recovery (i.e. 66-baseline score).
Non-parametric Friedman test was also conducted to es-
timate any changes in fatigue and relaxation levels
within sessions across the treatment. For all the analyses,
we set significance level at p < 0.05, and then applied
Bonferroni correction when multiple comparisons were
made. We report Median and Interquartile Range (IQR)
unless otherwise specified.
Results
All ten participants completed all ten sessions of the
treatment. The study lasted nine months and one week,
counted from the first session of the first participant to
the follow-up session of the last patient. No severe ad-
verse events were reported. Overall, 1485 tasks were
completed (Point: 20.5%; Reach: 41.3%; Grasp: 23.4%;
Fruitchamp: 14.9%); only 1.35% used the mirror mode.
Primary outcomes
Rehabilitation dose and training intensity
Table 3 summarizes all analyzed components of the re-
habilitation dose. The median duration across partici-
pants of the training sessions increased from 26.8 min
(IQR: 20.6 to 32.7) in the first session to 37.2 min in the
last session (IQR: 30.9 to 45.6; non-significant trend,
Z = 1.687, p = 0.074, effect size r = 0.377). The total
training time across all ten sessions was 403 min (IQR:
331 to 417). More importantly, the median effective
training time per session increased from 16.5 min (IQR:
12.5 to 20.1) in the first session to 32.1 min in the last
session (IQR: 23.9 to 37.9; Z = 2.701, p = 0.007,
r = 0.604). The total effective training time provided
across the ten sessions was 290 min (IQR: 246 to 329).
The median number of goal-directed movements per
session increased from 212.0 (IQR: 152.0 to 301.3) in the
first session to 476.5 in the last session (IQR: 432.3 to
637.0; Z = 2.805, p = 0.005, r = 0.627), with a maximum
of 517.0 (IQR: 373.0 to 624.3) in session #7 (Fig. 2). The
total of goal-directed movements completed by patients
across the ten sessions was 4713 (IQR: 3669 to 5293).
Notably, the intensity of the training, defined as the
number of goal-directed movements per minute of ef-
fective training time, increased progressively from 13.2
(IQR: 11.4 to 15.9) in the first session to 17.3 move-
ments in the last session (IQR: 16.6 to 18.7; Z = 2.089,
p = 0.037, r = 0.467; Fig. 2).
Secondary outcomes
Upper limb function
Changes in FMA-UE scores were observed across the
different assessment time points (χ2(2) = 9.892,
p = 0.007). When performing a post-hoc analysis, FMA-
UE score increased from 42.0 (IQR 24.75 to 53.0) at T0
(baseline) to 44.5 at T1 (IQR: 26.25 to 54.75; Z = 1.552,
p = 0.131, effect size r = 0.347) and increased to 45.5 at
T2 (IQR: 27.0 to 57.0; Z = 2.105, p = 0.035, r = 0.471;
Table 5). Participants P2 and P4 improved in FMA-UE
more than the MCID at post-treatment and follow-up
(P2: 47➔54➔54; P4: 17➔24➔26). Participant P10 also
improved over the MCID at follow-up (54➔55➔61).
Table 4 shows FMA-UE scores for each participant.
Studies suggest that motor recovery is better captured in
terms of change in functional scores, rather than of final
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endpoint [35]. Thus, we also analyzed the proportion of
recovery obtained after the training and the follow-up,
by calculating the score difference normalized for the
maximum recovery possible. This measure better con-
trols for individual differences at baseline and possible
ceiling effect. After the VR-based intervention, the me-
dian improvement rate was of 5.3% from T0 to T1, and
of 15.4% from T0 to T2. In both cases, the improvement
was significantly greater than zero (Wilcoxon signed-
rank test; T0-T1: p = 0.038; T0-T2: p = 0.014).
Active range of motion
A significant pre-post improvement in AROM was ob-
served for shoulder flexion (χ2(2) = 9.297, p = 0.010),
likely the joint movement solicited the most in the en-
semble of VR exercises. Shoulder flexion increased from
105.0° (IQR: 63.8° to 118.8°) at T0 (baseline) to 117.5°
(IQR: 71.3° to 133.8°; Z = 1.843, p = 0.065, effect size
r = 0.412) at T1 (post-treatment) and significantly to
117.5° (IQR: 77.5° to 131.3°; Z = 2.770, p = 0.007,
r = 0.619) at T2 (follow-up). A positive change was also
observed for forearm pronation (χ2(2) = 6.889,
p = 0.032). Forearm pronation increased from 62.5°
(IQR: 0.0° to 83.8°) at T0 to 87.5° (IQR: 56.3° to 90.0°;
Z = 2.390, p = 0.027, r = 0.534) at T1 and to 87.5° (IQR:
57.5° to 90.0°; Z = 1.714, p = 0.128, r = 0.383) at T2. No
significant changes in AROM were found for the rest of
upper limb movements measured (Table 5).
Muscle strength
Strength for each muscle group assessed (i.e., shoulder
flexion, elbow extension, wrist extension, forearm supin-
ation, forearm pronation) showed an improvement of
0.5 points in mMRCS at follow-up compared to baseline
(Table 5). These changes were not statistically significant
(p > 0.05).
Functional independence
Participants showed high levels of function both before
and after the treatment. Consequently, FIM scores
showed no change from baseline (121.5; IQR: 106.3 to
125.3) to post-treatment (121; IQR: 105 to 123) and to
follow-up assessments (121.5; IQR: 108.8 to 123.8;
χ2(2) = 0, p = 1; Table 5). No changes were observed for
the six “self-care” items, which are sensitive to changes
in paretic upper limb function, between baseline (41;
Table 3 Differences in the rehabilitation dose between the first and last sessions. * Wilcoxon signed-rank test, p < 0.05
Session #1
Median
(IQR)
Session #10
Median
(IQR)
Total
Median
(IQR)
p-value
(Session #1 vs. #10)
Duration of training (minutes) 26.8
(20.6 to 32.7)
37.2
(30.9 to 45.6)
403
(331 to 417)
0.074
Effective training time (minutes) 16.5
(12.5 to 20.1)
32.1
(23.9 to 37.9)
290
(246 to 329)
0.007*
Goal-directed Movements 212.0
(152.0 to 301.3)
476.5
(432.3 to 637.0)
4713
(3669 to 5293)
0.005*
Goal-directed movements per
minute of Effective training time
13.2
(11.4 to 15.9)
17.3
(16.6 to 18.7)
N/A 0.037*
Fig. 2 Individual, median and IQR values for Goal-directed Movements (left) and Training Intensity (right) at each session
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Table 4 FMA-UE and improvement rates for each participant at baseline (T0), post-assessment (T1) and follow-up (T2)
FMA-UE P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
Baseline (T0) 36 47 55 17 21 37 57 18 50 54
Post-treatment (T1) 33 54 55 24 23 38 58 17 51 55
Follow-up (T2) 30 54 58 26 23 39 59 19 52 61
Improvement rate at T1 −10% 37% 0% 14% 4% 3% 11% −2% 6% 8%
Improvement rate at T2 −20% 37% 27% 18% 4% 7% 22% 2% 13% 58%
Table 5 Median and IQR of primary and secondary clinical outcomes at baseline (T0), post-treatment (T1) and follow-up (T2). + Fried-
man test, p < 0.05; * Wilcoxon signed-rank test, p < 0.025 (Bonferroni corrected)
Baseline (T0)
Median
(IQR)
Post-treatment
(T1)
Median
(IQR)
Follow-up (T2)
Median
(IQR)
Friedman test Wilcoxon signed-rank test
p-value p-value
T0 to T1
p-value
T0 to T2
FMA-UE 42.0
(24.75 to 53.00)
44.5
(26.25 to 54.75)
45.5
(27.0 to 57.0)
0.007+ 0.131 0.035
AROM (in °)
Shoulder flexion 105.0
(63.8 to 118.8)
117.5
(71.3 to 133.8)
117.5
(77.5 to 131.3)
0.010+ 0.065 0.007*
Elbow extension −8.5
(−10.0 to −1.3)
−7.5
(−10.0 to 0.0)
−5.0
(−10 to 0)
0.420
Wrist extension 35.0
(6.3 to 55.0)
37.5
(8.8 to 55.0)
45.0
(22.5 to 60.0)
0.095
Forearm supination 62.5
(5.0 to 78.8)
57.5
(12.5 to 83.8)
67.5
(12.5 to 80.0)
0.131
Forearm pronation 62.5
(0.0 to 83.8)
87.5
(56.3 to 90.0)
87.5
(57.5 to 90.0)
0.032+ 0.027 0.128
mMRCS
Shoulder flexion 3
(3.0 to 3.8)
3.5
(3.0 to 4.0)
3.5
(3.0 to 4.0)
0.156
Elbow extension 2.5
(2.0 to 3.0)
3
(2.3 to 3.8)
3
(2.3 to 4.0)
0.074
Wrist extension 3
(1.5 to 4.0)
3
(2.3 to 4.0)
3.5
(2.3 to 4.0)
0.174
Forearm supination 3
(1.3 to 4.0)
3.5
(1.5 to 4.0)
3.5
(1.5 to 4.0)
0.424
Forearm pronation 3
(0.5 to 4.0)
3.5
(2.3 to 4.0)
3.5
(3.0 to 4.0)
0.350
FIM 121.5
(106.3 to 125.3)
121
(105 to 123)
121.5
(108.8 to 123.8)
1
VAS
Shoulder flexion 0
(0 to 6)
1
(0 to 2)
0
(0 to 1.75)
0.368
Elbow extension 0
(0 to 4)
0
(0 to 0)
0
(0 to 0)
0.146
Wrist extension 0
(0 to 4)
0
(0 to 0)
0
(0 to 0)
0.0498+ 0.103 0.103
Forearm supination 0
(0 to 0)
0
(0 to 0)
0
(0 to 0)
0.135
Forearm pronation 0
(0 to 0)
0
(0 to 0)
0
(0 to 0)
0.368
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IQR: 37.5 to 42), post-treatment (41; IQR: 37 to 42) and
follow-up assessments (41.5; IQR: 38.3 to 42; χ2(2) = 4,
p = 0.135).
Pain ratings
Overall, pain levels as measured by the VAS scale at
baseline, post-treatment, and follow-up were low all
across the treatment, confirming no negative long-
lasting effects due to the VR-based intervention. Import-
antly, pain levels did not increase during the treatment
period for any joint (all p > 0.05; Table 5), meaning that
physical activity carried out during VR intervention was
well tolerated.
Relationship between motor improvement and training
intensity
We explored any eventual relationship between the re-
habilitation dose or training intensity and the clinical
outcomes capturing any significant change after the
intervention, namely FMA-UE and AROM of shoulder
flexion. We could not establish any relationship between
the total active therapy time with either pre-post
changes in FMA-UE (R2 = 0.011) or AROM of shoulder
flexion (R2 = 0.027). The total dose of goal-directed
movements could not explain the changes either in
FMA-UE (R2 = 0.058) or in AROM of shoulder flexion
(R2 = 0.017). Similarly, an examination of the median
training intensity achieved by each patient did not ap-
pear to be able to predict changes in FMA-UE
(R2 = 0.115) and AROM of shoulder flexion
(R2 = 0.016). Importantly, however, the increase in train-
ing intensity observed between the first and last sessions
partially explained the changes in AROM of shoulder
flexion (R2 = 0.187, p = 0.212), a relationship that be-
came stronger and significant at the follow-up assess-
ment (R2 = 0.598, p = 0.009; Fig. 3). Thus, the more
patients increased their training across sections, the bet-
ter the functional outcome. This relationship was spe-
cific for shoulder flexion, i.e. the targeted joint in most
of the VR activities, but it was not present for general
upper limb function, as captured by FMA-UE scores
(R2 = 0.018).
Safety and acceptance of technology
Tolerance to VR intervention
All participants started every session with similar and
low levels of fatigue (median score: 1; IQR: 1 to 3.8;
χ2(9) = 7.730, p = 0.562; Table 6). When comparing the
level of fatigue before (Q1) and after (Q3) each session,
we found no statistical difference (χ2(19) = 18.137,
p = 0.513). However, the median level of fatigue in ses-
sion #2 was moderate (median score: 5.5; IQR: 1.5 to 6;
Z = 2.545, p = 0.01, effect size r = 0.569). This occa-
sional increase in fatigue may be related to the
considerable increase in the rehabilitation dose from ses-
sion #1 to session #2, once participants assimilated the
technology (see Fig. 2). Regarding relaxation (stress)
levels, participants came to each session with similar
and high levels of relaxation (median score: 7; IQR: 5.3
to 7; χ2(9) = 9.203, p = 0.419; Table 6). When comparing
the relaxation level before (Q2) and after (Q4) each ses-
sion, we observed no difference (χ2(19) = 25.386,
p = 0.148), meaning that the intensive VR intervention
did not increase participants’ stress.
Adverse event monitoring
In addition to overall pain ratings at baseline and post-
treatment, participants reported any eventual pain felt at
the level of the upper limbs and trunk during the train-
ing (Q5; Table 6). Self-reported pain was kept low, with
no significant changes across sessions (χ2(9) = 8.911,
p = 0.446). Three adverse events were reported. Partici-
pant P1 reported increased pain in the shoulder area be-
fore the training (from session #7 onwards). Debriefing
with the participant and her usual therapist could not
reveal the cause of that pain. Participant P4 was admin-
istered Botox in upper and lower limbs the day before
session #4, which led to higher level of pain in subse-
quent sessions. Participant P3 was particularly sensitive
to screen exposure and needed headache medication.
For this patient, the duration of the therapy sessions was
reduced to 30 min.
Self-evaluation
Participants reported a continuous feeling of im-
provement on mobility (Q6) across the sessions
(χ2(9) = 8.037, p = 0.530; Table 6). This self-reported
improvement significantly increased from 4 (IQR: 1.5
to 6.3) in the first session to 7 (IQR: 5.3 to 7;
Fig. 3 Scatter plot and linear regression between changes in
training intensity (session 10 vs. session 1) and changes in AROM of
shoulder flexion scores (follow-up vs. baseline). ** Wilcoxon signed-
rank test, p < 0.01
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Z = 2.136, p = 0.027, effect size r = 0.478) in the
last session (Table 7).
Acceptance of technology
From the first session on, participants showed high levels
of concentration (Q7; median score: 7, IQR: 7 to 7) and
immersion (Q8; median score of feeling at hospital envir-
onment: 1, IQR: 1 to 1), even forgetting that they were at
the hospital (Table 7). Participants identified to a great
extent their movements corresponding to those of the
avatar (Q9; median score: 6, IQR: 5.3 to 7), and this
perception was maintained across sessions, meaning
that the self-identification with avatar’s movements was
kept constant (Table 7). Participants liked to a great ex-
tent performing the exercises (Q10; median score: 5,
IQR: 4 to 7), and were comfortable with the demanded
movements (Q11; median score: 7, IQR: 7 to 7) while
being aware of the rehabilitative intention of the exer-
cises (Q12; median score: 5, IQR: 4.5 to 7). At the end
of the treatment, they also reported some interest in
having an improvement in the graphical quality of the
avatar (Q13; median score: 4, IQR: 1.3 to 6.8). In all
cases, this acceptance of technology was intact after ten
sessions of training (Table 7; all p > 0.05).
Motivation
Participants explicitly expressed their willingness to con-
tinue with the VR training both at hospital (Q14; median
score after session #1: 6, IQR: 4 to 7) and at home (Q15;
median score after session #1: 7, IQR: 4.3 to 7), confirm-
ing their adherence to the VR intervention (Table 7).
These levels of motivation were maintained intact after
ten sessions of training (p > 0.05).
Discussion
Primary outcomes
The results of this pilot study on chronic stroke show
that dedicated VR-based functional training of the upper
limb is able to provide high rehabilitation doses, both in
terms of active training time and repetitions per session
(i.e., training intensity). Participants received a total of
290 min of active VR-based functional training of the
upper extremity, with a total duration of the training
sessions of 403 min. The median duration of the training
session (including breaks and time between exercises)
continuously increased up to 37.2 min in the last ses-
sion, which approaches the therapy target of rehabilita-
tion guidelines [10]. More importantly, after participants
had become familiarized with the system (mostly during
the first session), the VR system allowed for very effi-
cient training sessions, with up to 32.1 min of effective
physical activity of the upper limb in the last session.
The rest of the time was dedicated to the selection of
the exercises composing the session and the pauses be-
tween exercises. This translates into an efficiency rate
(relation between time of therapy session and time spent
in active therapy) of 86.3% for the VR-based interven-
tion. This result supports recent evidence proving that
VR-based treatments after stroke can be 10% more
Table 6 Evolution of questionnaire scores related to Safety aspects across sessions
Questions Session #
1 2 3 4 5 6 7 8 9 10
Tolerance to VR intervention
Q1: Before the session,
how tired do you feel?
1
(1 to 3.8)
1
(1 to 2.5)
1.5
(1 to 2.8)
2
(1 to 3)
2
(1 to 4)
1
(1 to 4)
3.5
(1 to 5)
3
(1.5 to 5.8)
1
(1 to 4.5)
1
(1 to 2.5)
Q3: After the session,
how tired do you feel?
1
(1 to 5.8)
5.5
(1.5 to 6)
1
(1.5 to 6)
2
(1 to 5)
2
(1 to 5)
2
(1 to 6)
3.5
(1 to 5.8)
3.5
(1.3 to 6)
2.5
(1 to 5.8)
2
(1 to 5.8)
Q2: Before the session,
how relaxed do you feel?
7
(5.3 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
7
(7 to 7)
Q4: During the session,
how relaxed did you feel?
7
(6.3 to 7)
7
(7 to 7)
6
(4 to 7)
7
(6.3 to 7)
7
(7 to 7)
7
(4 to 7)
7
(6.3 to 7)
7
(6 to 7)
7
(5.3 to 7)
7
(6.3 to 7)
Adverse event monitoring
Q5: During the exercises,
did you feel any unusual pain
(e.g. stronger) at the level of the
upper limbs (arms, joints, hands)
or the trunk?
1
(1 to 1.8)
1
(1 to 2.5)
1
(1 to 1)
3
(1 to 5)
1
(1 to 3)
2
(1 to 3)
1.5
(1 to 5)
3.5
(1 to 5.8)
1
(1 to 1.8)
1
(1 to 4.5)
Self-evaluation
Q6: After the session, do you
feel any improvement of you
movements
(e.g., larger movements,
more precise, etc.)?
4
(1.5 to 6.3)
4.5
(4 to 5.8)
6
(4.3 to 7)
6
(3.5 to 7)
6
(5 to 7)
6
(4.5 to 6.8)
5.5
(5 to 6)
6
(4.5 to 7)
6
(4 to 6)
7
(5.3 to 7)
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efficient (i.e., higher activity rate) than conventional ther-
apy (77% vs. 67% of total therapy time), 20% (81% vs.
61%) for severely impaired patients [25].
Animal studies suggest that 400–600 repetitions per
day of functional tasks are required to induce structural
neurological changes [36]. In our study, participants
completed a median of 4713 goal-directed movements
(which represented 1834 task repetitions). This trans-
lates to an average of 471 movements (183 tasks) com-
pleted per session, which represents a quantitatively
higher dose as compared to average functional upper ex-
tremity repetitions (45 ± 13) provided in outpatient clin-
ical practice [37]. Indeed, recent studies show that the
standard dose can be increased with intensive, high-
repetition programs [36]. Technology-mediated inter-
ventions such as virtual reality [15] and robotic plat-
forms [38] have demonstrated higher dose efficiency. In
the present study, VR-mediated training delivered up to
17 goal-directed movements per minute (~8–9 com-
pleted tasks per minute), a training intensity 10–15
times higher as in standard therapy [39].
Secondary outcomes
Participants improved in FMA-UE score, with an overall
15.4% improvement rate at follow-up. Importantly, three
patients improved beyond MCID, meaning that the VR-
based intervention may have contributed to further clin-
ical improvement even in a late chronic phase. Our re-
sults bring further evidence of how highly intensive
upper limb training with specific shoulder and arm
tasks, delivered by means of a embodied VR system,
may help improve AROM for the shoulder flexion in
moderate-to-severe chronic stroke patients. This is in
line with a recent study that has reported AROM im-
provements in chronic stroke using VR-based training of
moderate intensity (72 repetitions per session), especially
in patients with mild upper limb motor deficits [40].
We note that FIM scores did not change after the
intervention. This is likely due to the high-level of func-
tional independence already achieved by patients at
baseline (median value was 121 out of 126). Another fac-
tor could be the fact that residual deficits on chronic pa-
tients usually remain for distal and more complex finger
movements, which are not targeted by the current VR
exercises. Interestingly, a large study involving 376 pa-
tients who received 40 h of training in 4 weeks did re-
port an increase in FIM scores for both a VR group and
a conventional therapy group, with the VR group im-
proving significantly more than the conventional therapy
group [41]. Thus, longer and/or more specific upper
limb training may be necessary to elicit positive FIM
changes in chronic stroke patients.
Table 7 Acceptance of technology, motivation and self-evaluation questions in the first and last sessions. * Wilcoxon signed-rank
test, p < 0.05
Questions First Session
Median(IQR)
Last Session
Median(IQR)
Wilcoxon test
p-value
Self-evaluation
Q6: After the session, do you feel any improvement of you movements
(e.g., larger movements, more precise, etc.)?
4
(1.5 to 6.3)
7
(5.3 to 7)
0.027*
Acceptance of technology
Q7: During the exercises, were you concentrated on the task? 7
(7 to 7)
7
(7 to 7)
0.786
Q8: During the exercises, did you have the feeling of being in the
hospital room?
1
(1 to 1)
1
(1 to 1.8)
0.103
Q9: Did the movements of the character reflect your movements? 6
(5.3 to 7)
6.5
(5.3 to 7)
0.546
Q10: During the exercises, did you feel comfortable with the
requested movements?
5
(4 to 7)
7
(6 to 7)
0.090
Q11: Did you like the exercises? 7
(7 to 7)
7
(7 to 7)
0.317
Q12: Did you have the impression of doing rehabilitation exercises? 7
(4.5 to 7)
7
(3 to 7)
0.706
Q13: Would you like the character to look more realistic? 1
(1 to 4.8)
4
(1.3 to 6.8)
0.438
Motivation
Q14: Would you like to spend more time doing the exercises at the hospital? 6
(4 to 7)
7
(3.3 to 7)
0.595
Q15: Would you like to continue doing the exercises at home? 7
(4.3 to 7)
7
(5.3 to 7)
1.000
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We found that the improvements in AROM of shoul-
der flexion observed after the intervention, and particu-
larly at the follow-up assessment, could be partially
explained by the increase in training intensity across ses-
sions, but not by the rehabilitation dose per se (neither
in number of movements or time spent in the training).
This preliminary finding seems to be in line with the rec-
ommendations of the recently formed Stroke Recovery
and Rehabilitation Roundtable, which advocates that "re-
covery trials need to consider serially applied kinematic/
kinetic measurements alongside clinical assessments to
distinguish between restitution and compensation. A core
set of kinetics and kinematic outcomes needs to be estab-
lished" [42]. Within this context, VR systems, in particular
motion capture technology, can help quantify changes in
motor recovery in an objective fashion. Indeed, kinematic
analyses of movement quality (based on high-quality mo-
tion tracking recordings) have been strongly advocated to
be incorporated into clinical assessments as they may cap-
ture better changes in motor control [43, 44].
Embodied technology has been recently proposed for
neuroprosthetics [45], and treatment of different path-
ologies, such as pain management [46–48] or eating dis-
orders [49]. In the present study, we used a novel VR
system for motor rehabilitation after stroke that provides
embodied visuomotor feedback. In this regard, a ran-
domized clinical trial with stroke patients has shown
that VR-mediated embodied feedback for gait training
may entrain several brain areas (probably encompassing
the mirror neuron system) involved in motor planning
and learning, thus leading to an enhanced motor per-
formance [50]. In this context, VR has the unique poten-
tial to manipulate visual feedback of the movement
made by the participant, in a way which potentially al-
lows the selection of patterns of sensorimotor coherence
aimed at activating specific sensorimotor brain circuits
(e.g., action observation system [51] and other monitor-
ing systems [52]). The individual contributions of the
different priming techniques and cognitive principles in-
cluded in the provided feedback were beyond the scope
of this study and need to be addressed in further studies
using dedicated designs.
The results of the present study suggest that it is
possible to improve functional skills of the upper limb
in stroke survivors with intensive training, even in
the early chronic (6 months post stroke) and later
chronic phases (54 months post stroke) [13]. How-
ever, secondary outcomes did not show clinical im-
provements after 403 min of training delivered
(290 min effective training time). Thus, besides deliv-
ery of high training intensity, higher rehabilitation
volumes are required to affect FMA and FIM scores
in chronic stroke patients who still present functional
deficits at everyday life activities. Further studies with
stratified groups and different motor assessments
could also help to identify (i) the patient profiles that
benefit the most from this embodied VR technology,
and (ii) the motor outcomes that capture best the
eventual improvements.
Safety and acceptance of technology
Participants reported low levels of fatigue and stress
generated during the training sessions. Despite the fact
that the rehabilitation dose and intensity increased, espe-
cially from session #2 onwards, the level of fatigue did
not. No serious adverse event was reported in the
present study. This is very likely because the VR exer-
cises were specifically designed for neurorehabilitation
purposes by clinicians and physical therapists, and
were validated with acute stroke patients before pro-
ceeding to this study [53, 54]. This approach differenti-
ates the current embodied VR device from other
attempts to adopt computer games for stroke rehabilita-
tion, whereby consumer video consoles are used to pro-
vide motor training [17, 18]. Approaches based on the
adoption of off-the-shelf, not clinically customized, solu-
tions have serious limitations, in that therapy objectives
are not taken into account, with the type and level of ac-
tivities not being tuned to stroke patients’ residual abil-
ities. In a recent study that used off-the-shelf, non-
adapted, videogames for upper extremity training in sub-
acute stroke [17], and with similar training doses deliv-
ered, participants reported adverse events such as
dizziness (15%), headaches (13%) or nausea (6%).
Motivation and engagement are intrinsic component
of VR- and videogame-based interventions in stroke re-
habilitation [55]. They are related not only to compli-
ance and adherence to rehabilitation programs, but they
also influence intervention outcomes [24]. In the current
study, participants showed the highest levels of adher-
ence to the rehabilitation program and motivation to
continue therapy both at hospital and at home. This
may relate to the very high levels of self-perceived im-
provement in mobility reported by participants at the
end of the treatment. Importantly, during the debriefing
several participants reported higher self-confidence
levels at activities of daily living at home, with more use
of the affected arm, therefore reducing non-learned use
effect. This catalyzing effect may have contributed to the
observed functional improvements during the follow-up
assessment.
Limitations of the study
Besides the assessment of the primary outcome (training
intensity and dose), this pilot study included the collec-
tion of several clinical outcomes. Within this regard, the
study presents several limitations, the most important
being the lack of a control group and a relatively small
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sample size, which undermine the possibility of provid-
ing evidence on therapy effectiveness. The level of phys-
ical activity of participants (or inactivity, in particular of
the affected limb) prior to the intervention could also
not be assessed. This is particularly critical in chronic
stroke research, as patients could be functioning at a
level below their full potential due to disuse. The dur-
ation of the training sessions provided in this study, and
consequently the delivered dose, may have been affected
by the dependence on the outpatient transportation ser-
vice, planned for one hour after the session started. Train-
ing schedules (twice a week) were also adapted to both
outpatient population and physical therapist availability.
Conclusion
This pilot study has shown the feasibility and safety of a
specific and intensive functional training of upper extrem-
ity in chronic stroke survivors with a dedicated VR system
for neurorehabilitation and based on closed visuomotor
loop via embodied visual feedback. The rehabilitation dose
was continuously increased, adjusting to patients’ needs to
maximize the training efficacy. Functional and motor out-
comes suggest that highly intensive VR training may be
beneficial for breaking the “plateau” of functional recovery
in chronic stroke. To further assess the potential of such
task-specific VR-based training (as compared to standard
of care) for upper extremity rehabilitation in people with
acute stroke, another study with intensive intervention
(five times a week for four weeks) and fully monitoring of
dose parameters is underway.
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